News | January 29, 2023
Vimta Labs reports Q3 FY23 consolidated PAT at Rs. 10.24 Cr
The company has reported total income of Rs. 78.50 crores during the period ended December 31, 2022
The company has reported total income of Rs. 78.50 crores during the period ended December 31, 2022
It will help upgrade the infrastructure and technologies of the country's biopharmaceuticals and in-vitro diagnostic industry
The company will engage with the agency to resolve the import alert at the earliest.
The company has reported total income of Rs. 211.36 crores during the period ended December 31, 2022
Standalone Q3 FY23 revenue stood at Rs. 626.5 crore as against Rs. 594.8 crore, a growth of 5% YoY
The United States Food and Drug Administration (USFDA) conducted an inspection at Gland Pharma Limited API Facility at JNPC, Visakhapatnam
The Durezol brand and generic had US sales of approximately US $40 million MAT for the most recent twelve months ending in Nov 2022 according to IQVIA
The company has reported total income of Rs. 6848.5 crores during the period ended December 31, 2022
The company has reported total income of Rs. 2481 crores during the period ended December 31, 2022
Biocon Foundation has pioneered a mHealth-technology-based (mobile health) oral cancer screening program in India
Subscribe To Our Newsletter & Stay Updated
